Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Cancer. 2015 Mar 4;121(13):2253–2261. doi: 10.1002/cncr.29308

Table 2.

Key Grade 3–5 Adverse Event Incidence, Any Attribution

A (n=42) B (n=44) C (n=48)
Grade Grade Grade
3 4 5 3 4 5 3 4 5
Adverse Event Type (n) (n) (n) (n) (n) (n) (n) (n) (n)
Anemia 7 0 0 3 1 0 5 1 0
Febrile neutropenia 3 0 0 2 0 0 2 0 0
Fatigue 6 0 0 9 0 0 5 0 0
Rash acneiform 2 0 0 0 0 0 4 0 0
Diarrhea 0 0 0 1 0 0 4 0 0
Nausea 5 0 0 3 0 0 4 0 0
Vomiting 3 0 0 1 0 0 2 0 0
Lung Infection 3 0 1 2 0 0 3 0 0
Neutrophil count decreased 3 9 0 5 8 0 6 14 0
Platelet count decreased 1 2 0 1 5 0 2 4 0
Anorexia 3 0 0 4 0 0 2 0 0
Dehydration 1 0 0 2 0 0 3 0 0
Hyperglycemia 1 0 0 6 0 0 5 3 0
Hyponatremia 1 0 0 2 0 0 8 0 0
Arthralgia 3 0 0 4 0 0 3 0 0
Myalgia 1 0 0 3 0 0 0 0 0
Dyspnea 10 1 0 6 0 0 4 2 0
Thromboembolic event 0 1 0 2 2 0 0 0 0